Your browser doesn't support javascript.
loading
Engaging in advocacy during medical training: assessing the impact of a virtual COVID-19-focused state advocacy day.
Yu, Zizi; Moustafa, Danna; Kwak, Ruby; O'Connor, Daniel M; Cavanaugh-Hussey, Margaret W; Huang, Jennifer T; LaChance, Avery H.
Afiliação
  • Yu Z; Harvard Medical School, Boston, Massachusetts, USA.
  • Moustafa D; Harvard Medical School, Boston, Massachusetts, USA.
  • Kwak R; Harvard Medical School, Boston, Massachusetts, USA.
  • O'Connor DM; Harvard Combined Dermatology Residency Program, Boston, Massachusetts, USA.
  • Cavanaugh-Hussey MW; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Huang JT; Division of Dermatology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • LaChance AH; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA alachance@bwh.harvard.edu.
Postgrad Med J ; 98(1159): 365-368, 2022 May.
Article em En | MEDLINE | ID: mdl-33441479
ABSTRACT

PURPOSE:

The physician voice is crucial to shaping health policy and public health guidelines, particularly during COVID-19. However, there are gaps in health policy and advocacy education within graduate medical education. This study sought to characterise the impact of a virtual COVID-19 focused advocacy day among medical trainees in Massachusetts. STUDY

DESIGN:

The half-day event featured speakers drawn from government relations experts, physician advocates, and state and federal legislators as well as breakout discussions among attendees. A 25-question Redcap survey and list of resources/opportunities for continued advocacy was administered to all participants at event's conclusion on 19 May 2020.

RESULTS:

There were 60 responses from 141 participants (43% response rate). One-third reported no prior formal health policy instruction, and over half reported getting information from news publications, social media and peers. 58% believed physician involvement in advocacy to be 'extremely important' prior to COVID-19; 83% believed the same after onset of COVID-19 (p<0.0001). The most common barriers to advocacy engagement were lack of time and knowledge. Most attendees felt participation increased their knowledge and likelihood to engage in the COVID-19 response, imparted useful skills/knowledge for continued advocacy, increased their interest in future similar events, and that such events should be available to all trainees.

CONCLUSIONS:

Trainees recognise the importance of health policy and advocacy and value opportunities to gain the necessary skills/knowledge to effect tangible change. Virtual advocacy days can be replicated nationwide to help trainees learn about advocacy efforts and find their legislative voices during COVID-19 and beyond.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article